Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Invariant NKT cells limit… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Invariant NKT cells limit activation of autoreactive CD1d-positive B cells.

Artikel i vetenskaplig tidskrift
Författare Fredrik Wermeling
Sara M Lind
Emilie Domange Jordö
Susanna Cardell
Mikael C I Karlsson
Publicerad i The Journal of experimental medicine
Volym 207
Nummer/häfte 5
Sidor 943-52
ISSN 1540-9538
Publiceringsår 2010
Publicerad vid Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi
Sidor 943-52
Språk en
Länkar dx.doi.org/10.1084/jem.20091314
Ämnesord Animals, Antigens, CD1d, genetics, immunology, Apoptosis, immunology, Autoimmune Diseases, immunology, B-Lymphocytes, immunology, Cytokines, genetics, Humans, Lupus Erythematosus, Systemic, immunology, Lymphocyte Activation, immunology, Lymphocyte Depletion, Mice, Natural Killer T-Cells, immunology, Spleen, immunology, physiology
Ämneskategorier Mikrobiologi inom det medicinska området

Sammanfattning

Faulty activation of autoreactive B cells is a hallmark of autoimmune diseases like systemic lupus erythematosus (SLE). An important feature restricting activation of autoreactive B cells is efficient removal of apoptotic material. Mounting evidence also connects a primary defect in invariant natural killer T (iNKT) cells to autoimmune disease development. However, exactly how this unconventional T cell subset is involved remains to be defined. Here, we identify a suppressive role for iNKT cells in a model where autoantibody production is triggered by an increased load of circulating apoptotic cells, resembling the situation in SLE patients. Absence or reduction of iNKT cells as well as absence of CD1d-expression on B cells, needed for direct iNKT-B cell interaction, leads to increased autoreactive B cell activation and symptoms of disease. The suppression mediated by the iNKT cells is observed before B cell entry into germinal centers and can be rescued by transferring iNKT cells to deficient mice. This links iNKT cells to handling of dying cells and identifies a novel peripheral tolerance checkpoint relevant for autoimmune disease. Thus, these observations connect two clinical observations in SLE patients previously considered to be unrelated and define a new target for immunotherapy.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?